Evolving Cardiac Electrical Therapies for Advanced Heart Failure Patients.
Circ Arrhythm Electrophysiol
; 14(4): e009668, 2021 04.
Article
in En
| MEDLINE
| ID: mdl-33858178
ABSTRACT
Symptomatic heart failure (HF) patients despite optimal medical therapy and advances such as invasive hemodynamic monitoring remain challenging to manage. While cardiac resynchronization therapy remains a highly effective therapy for a subset of HF patients with wide QRS, a majority of symptomatic HF patients are poor candidates for such. Recently, cardiac contractility modulation, neuromodulation based on carotid baroreceptor stimulation, and phrenic nerve stimulation have been approved by the US Food and Drug Administration and are emerging as therapeutic options for symptomatic HF patients. This state-of-the-art review examines the role of these evolving electrical therapies in advanced HF.
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Autonomic Nervous System
/
Stroke Volume
/
Electric Stimulation Therapy
/
Ventricular Function, Left
/
Heart
/
Heart Failure
/
Myocardial Contraction
Type of study:
Diagnostic_studies
/
Prevalence_studies
/
Risk_factors_studies
Limits:
Animals
/
Humans
Language:
En
Journal:
Circ Arrhythm Electrophysiol
Journal subject:
ANGIOLOGIA
/
CARDIOLOGIA
Year:
2021
Document type:
Article